Takaya, H.; Namisaki, T.; Asada, S.; Iwai, S.; Kubo, T.; Suzuki, J.; Enomoto, M.; Tsuji, Y.; Fujinaga, Y.; Nishimura, N.;
et al. ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. J. Clin. Med. 2022, 11, 1835.
https://doi.org/10.3390/jcm11071835
AMA Style
Takaya H, Namisaki T, Asada S, Iwai S, Kubo T, Suzuki J, Enomoto M, Tsuji Y, Fujinaga Y, Nishimura N,
et al. ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine. 2022; 11(7):1835.
https://doi.org/10.3390/jcm11071835
Chicago/Turabian Style
Takaya, Hiroaki, Tadashi Namisaki, Shohei Asada, Satoshi Iwai, Takahiro Kubo, Junya Suzuki, Masahide Enomoto, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura,
and et al. 2022. "ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability" Journal of Clinical Medicine 11, no. 7: 1835.
https://doi.org/10.3390/jcm11071835
APA Style
Takaya, H., Namisaki, T., Asada, S., Iwai, S., Kubo, T., Suzuki, J., Enomoto, M., Tsuji, Y., Fujinaga, Y., Nishimura, N., Sawada, Y., Kaji, K., Kawaratani, H., Moriya, K., Akahane, T., Matsumoto, M., & Yoshiji, H.
(2022). ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine, 11(7), 1835.
https://doi.org/10.3390/jcm11071835
